A phase I study of personalized peptide vaccination for advanced urothelial carcinoma patients who failed treatment with methotrexate, vinblastine, adriamycin and cisplatin.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples